Access cutting-edge opioid withdrawal treatment through this clinical trial at a research site in Philadelphia. Study-provided care at no cost to qualified participants.
Access opioid withdrawal specialists in Philadelphia at no cost
This study follows strict safety protocols and ethical guidelines
All study-related opioid withdrawal treatment provided free
A placebo-controlled trial in which male and female outpatients with an opioid use disorder who express interest in extended-release injectable naltrexone (XR-NTX) are randomized 1:1 to lofexidine/pregabalin or lofexidine/pregabalin placebo for withdrawal management and offered XR-NTX if after completing withdrawal.
Sponsor: University of Pennsylvania
Check if you qualify for this opioid withdrawal clinical trial in Philadelphia, PA
If you're searching for opioid withdrawal treatment options in Philadelphia, PA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Philadelphia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced opioid withdrawal specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.